Search
Search Results
##search.searchResults.foundPlural##
-
-
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1571PDF: 796HTML: 150 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3205PDF: 1225HTML: 8094 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2128PDF: 1555HTML: 252 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1318PDF: 822HTML: 10028cover letter to the editor: 163tile page: 245 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
711PDF: 462HTML: 6257 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3488PDF: 2380HTML: 1438 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1507PDF: 1177HTML: 174 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
10481PDF: 6312HTML: 21769 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2192PDF: 925HTML: 286 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
3936PDF: 1291HTML: 2250 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2661PDF: 995HTML: 2259 -
OUTLINE OF IRON METABOLISM, WITH EMPHASIS TO ERYTHROID CELLS iron Metabolism
1819PDF: 898Html: 300 -
THE HEMATOLOGICAL PARAMETERS AND BIOCHEMICAL MARKERS OF IRON STATUS IN ALFA-THALASSEMIA 3.7KB DELETION FROM METROPOLITAN REGION OF MANAUS, AMAZONAS, BRAZIL. alfa-Thalassemia 3.7 deletion From Amazonas, Brazil.
4076PDF: 594HTML: 354 -
Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia
2886PDF: 675HTML: 1922figure 1: 163figure 2: 172 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1575PDF: 1072HTML: 106 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1205PDF: 961HTML: 195 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
6856PDF: 3884HTML: 24863 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2483PDF: 937HTML: 2221 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
4692PDF: 1867HTML: 11025Fig 1: 216Fig 2: 175Fig 3: 295Fig 4: 181Fig 5: 172Fig 6: 169Fig 7: 181Fig 8: 174 -
-
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
1996PDF: 807HTML: 203 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1155PDF: 1042HTML: 182 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1352PDF: 874HTML: 1788 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3338PDF: 1281HTML: 1853Fig.1: 193Fig. 2: 196 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3480PDF: 1167HTML: 4986Incidence age-standardized rates for HL across the Mediterranean basin: 195







